April 12, 2018 / 5:38 AM / 14 days ago

BRIEF-Sensorion FY Operating Loss Widens To 9.5 Million Euros

April 12 (Reuters) - SENSORION SA:

* SENSORION REPORTS FULL YEAR 2017 RESULTS

* CASH AND CASH EQUIVALENTS AT END PERIOD EUR 7.6 MILLION VERSUS EUR 8.5 MILLION YEAR AGO

* FY OPERATING LOSS OF EUR 9.5 MILLION VERSUS LOSS OF EUR 8.4 MILLION YEAR AGO

* 2018 OUTLOOK: PHASE II CLINICAL DATA FOR LEAD DRUG-CANDIDATE, SENS-111

* 2018 OUTLOOK: INITIATION OF PHASE II CLINICAL TESTING FOR SENS-401

* SENS-401: PLANS PHASE 2 CLINICAL TRIAL IN CHEMOTHERAPY-TREATED PAEDIATRIC PATIENTS, MAY START AT BEGINNING OF 2019

* FY NET LOSS OF EUR 9.7 MILLION VERSUS LOSS OF EUR 8.9 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below